Nude mice injected with a CML cell line overexpressing ABCB1 and treated with bosutinib exhibited less of a response compared to nude mice injected with cells silenced for ABCB1. Here, ABCB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.